Literature DB >> 14628193

Activation of basal ganglia loops in idiopathic Parkinson's disease: a PET study.

A Thiel1, R Hilker, J Kessler, B Habedank, K Herholz, W-D Heiss.   

Abstract

Patients with idiopathic Parkinson's syndrome (IPS) show dysexecutive deficits which are not related to dementia. We investigated whether these deficits may be caused by a disturbed interaction of prefrontal cortex and selective basal ganglia loops. 5 healthy right-handed volunteers and 5 non demented IPS patients were studied with FDG PET while performing a gambling task paradigm. Control subjects and patients showed consistent bilateral activation of the dorsolateral prefrontal cortex (DLPFC) and the left caudate. Only controls activated the right cingulate, mesial prefrontal and frontoorbital cortex. Patients significantly deactivated the right thalamus. Thus missing frontoorbital and frontomesial activity may indicate an impairment of the basal ganglia loop in IPS, connecting those regions to the thalamus via the ventral striate. The connections between DLPFC and Thalamus via the left caudate remained intact. This impairment may be the neuroanatomical correlate for dysexecutive syndromes in IPS more related to misjudgement than cognitive impairment.

Entities:  

Mesh:

Year:  2003        PMID: 14628193     DOI: 10.1007/s00702-003-0041-7

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  26 in total

1.  Decreased ventral striatal activity with impulse control disorders in Parkinson's disease.

Authors:  Hengyi Rao; Eugenia Mamikonyan; John A Detre; Andrew D Siderowf; Matthew B Stern; Marc N Potenza; Daniel Weintraub
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

2.  Neural correlates of decision making with explicit information about probabilities and incentives in elderly healthy subjects.

Authors:  Kirsten Labudda; Friedrich G Woermann; Markus Mertens; Bernd Pohlmann-Eden; Hans J Markowitsch; Matthias Brand
Journal:  Exp Brain Res       Date:  2008-03-05       Impact factor: 1.972

Review 3.  Decision-making cognition in neurodegenerative diseases.

Authors:  Ezequiel Gleichgerrcht; Agustín Ibáñez; María Roca; Teresa Torralva; Facundo Manes
Journal:  Nat Rev Neurol       Date:  2010-10-12       Impact factor: 42.937

4.  The risky business of dopamine agonists in Parkinson disease and impulse control disorders.

Authors:  Daniel O Claassen; Wery P M van den Wildenberg; K Richard Ridderinkhof; Charles K Jessup; Madaline B Harrison; G Frederick Wooten; Scott A Wylie
Journal:  Behav Neurosci       Date:  2011-08       Impact factor: 1.912

5.  Betting on DBS: Effects of subthalamic nucleus deep brain stimulation on risk taking and decision making in patients with Parkinson's disease.

Authors:  Jason Brandt; Mark Rogerson; Haya Al-Joudi; Gila Reckess; Barnett Shpritz; Chizoba C Umeh; Noha Aljehani; Kelly Mills; Zoltan Mari
Journal:  Neuropsychology       Date:  2014-12-08       Impact factor: 3.295

6.  Cannabinoids and value-based decision making: implications for neurodegenerative disorders.

Authors:  Angela M Lee; Erik B Oleson; Leontien Diergaarde; Joseph F Cheer; Tommy Pattij
Journal:  Basal Ganglia       Date:  2012-07-28

7.  Connectivity of the subthalamic nucleus and globus pallidus pars interna to regions within the speech network: a meta-analytic connectivity study.

Authors:  Jordan L Manes; Amy L Parkinson; Charles R Larson; Jeremy D Greenlee; Simon B Eickhoff; Daniel M Corcos; Donald A Robin
Journal:  Hum Brain Mapp       Date:  2013-11-25       Impact factor: 5.038

Review 8.  Reward processing in neurodegenerative disease.

Authors:  David C Perry; Joel H Kramer
Journal:  Neurocase       Date:  2014-01-13       Impact factor: 0.881

Review 9.  Brain imaging studies in pathological gambling.

Authors:  Ruth J van Holst; Wim van den Brink; Dick J Veltman; Anna E Goudriaan
Journal:  Curr Psychiatry Rep       Date:  2010-10       Impact factor: 5.285

10.  Functional anatomy of outcome evaluation during Iowa Gambling Task performance in patients with Parkinson's disease: an fMRI study.

Authors:  Tomáš Gescheidt; Radek Mareček; Michal Mikl; Kristína Czekóová; Tomáš Urbánek; Jiří Vaníček; Daniel J Shaw; Martin Bareš
Journal:  Neurol Sci       Date:  2013-04-23       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.